Cargando…

Prolactinoma in a Male to Female Transgender Woman on Gender Affirming Hormone Therapy

Background: Estrogen promotes prolactin secretion and its role in prolactin secreting adenomas is still under investigation. The genesis and resolution of prolactinomas may be affected by gender affirming hormone therapy. Case Description: A 50 year old transgender female presented with new onset tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harned, Leighton K, Harper, Rene J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Reproductive Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089498/ http://dx.doi.org/10.1210/jendso/bvab048.1617

Ejemplares similares

ODP414 Incidence of Suicidal Events in Transgender Patients with Initiation of Gender Affirming Hormone Therapy
por: Elliott, Karma-Jaya, et al.
Publicado: (2022)

Effect on Kidney Function During Gender Affirming Hormonal Treatment in Transgender Individuals
por: Maheshwari, Arvind Kumar, et al.
Publicado: (2021)

Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
por: Da Silva, Eliane Dias, et al.
Publicado: (2021)

MON-195 Trans-transgender Female: Gender Identity Reversal Following Irreversible Gender Affirming Surgeries
por: Korpaisarn, Sira, et al.
Publicado: (2019)

PMON280 Effect of Gender Affirming Hormone Therapy (GAHT) on Adipose Tissue Morphology and Metabolism in Transgender Individuals
por: Shah, Manasi S, et al.
Publicado: (2022)

Cardiovascular Risk Factors in Transgender Women Undergoing Long-Term Gender-Affirming Hormone Therapy: A Cross-Sectional Study
por: Alvares, Leonardo A M, et al.
Publicado: (2021)

RF34 | PMON276 The Effect of Gender Affirming Hormone Therapy (GAHT) on Non-Conventional Cardiovascular Risk Markers in Transgender Men: A Systematic Review
por: Moreira Allgayer, Roberta Martins Costa, et al.
Publicado: (2022)

SUN-LB8 Cross Sex Hormone Therapy and Breast Cancer in Transgender Male to Female
por: Eldin, Randa Sharag, et al.
Publicado: (2020)

Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
por: Aranda, Gloria, et al.
Publicado: (2021)

MON-196 Gender-Affirming Hormonal Therapy and Incidence of Metabolic Syndrome and Cardiovascular Events in Patients with Gender Dysphoria
por: Mok, Mary, et al.
Publicado: (2019)

SAT422 Gender Affirming Hormone Therapy in a Non-Binary Individual with Swyer Syndrome
por: Yohannan, Jiby M, et al.
Publicado: (2023)

“It Wasn’t for the Sake of Me and My Mental Health”: Transgender People’s Perspective on the Role of Mental Health Providers in Initiating Gender-Affirming Hormones - a Qualitative Study
por: Maksutova, Mariam, et al.
Publicado: (2021)

A Cross Sectional Analysis of the Prevalence of Co-Morbidities in Older Transgender Individuals Receiving Hormone Affirming Therapy in Comparison With the General Population
por: Breda, Ido, et al.
Publicado: (2021)

ODP415 Inclusion Health Clinic: Gender-Affirming Hormone Therapy & Surgery Booklet and Review of Efficacy in Patient-Provider Encounters
por: Pulsiano, Sune Wolf, et al.
Publicado: (2022)

Management of Recurrent Deep Vein Thrombosis in a Transgender Woman
por: Oguz, Seda Hanife, et al.
Publicado: (2021)

Stability of Weekly Intramuscular Estradiol Cypionate in a Transgender Woman
por: Calzada, Stephanie, et al.
Publicado: (2021)

Breast cancer in a transgender woman undergoing gender-affirming exogenous hormone therapy
por: Villalba, Michael D., et al.
Publicado: (2023)

SUN-040 Hormone Replacement Therapy in Transgender Unmasks Testicular Tumor
por: Tran, Kelvin, et al.
Publicado: (2020)

SUN-048 Cardiometabolic Effects of Cross-Sex Hormone Therapy in Transgender Patients
por: Trebotic, Lana Kosi, et al.
Publicado: (2020)

Patient Characteristics Associated With the Receipt of Hormone Therapy Among Transgender Patients in the Veterans Health Administration
por: Wong, Denise H, et al.
Publicado: (2021)

Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study
por: Foster Skewis, Lucas, et al.
Publicado: (2021)

SUN-043 Galactorrhea and Hyperprolactinemia in a Transgender Female
por: Unnithan, Rachna, et al.
Publicado: (2020)

MON-LB040 Correlation Between Length of Hormone Therapy and Adverse Events in Transgender Veterans
por: Elliott, Karma-Jaya, et al.
Publicado: (2019)

SUN-052 Effects of Cross-Sex Hormone Therapy on Lipid Metabolism in Transgender Women and Men
por: Kelley, Carly, et al.
Publicado: (2020)

Muscle Strength in Transgender Women After Long-Term Hormone Therapy: A Cross-Sectional Study
por: Alvares, Leonardo A M, et al.
Publicado: (2021)

Body Composition of Transgender Women After Long-Term Hormone Therapy - a Cross-Sectional Study
por: Alvares, Leonardo A M, et al.
Publicado: (2021)

Clinical pearls of gender-affirming hormone therapy in transgender patients
por: Irving, Amanda, et al.
Publicado: (2018)

Gender-affirming Hormone Therapy and Risk of Diabetes in Transgender Persons
por: Tangpricha, Vin
Publicado: (2022)

OR25-4 Modulatory Effects of Estradiol on the Resting-State Functional Connectivity in Transwomen Following Gender Affirming Surgery
por: Schneider, Maiko, et al.
Publicado: (2019)

The Role of the Endocrinologist in the Gender Adequacy Process and the Barriers for Adequate Transgender Health Care
por: Saliba, Alexandra
Publicado: (2021)

OR25-4 Active Testosterone Treatment Impairs In Vitro Fertilization (IVF) Outcomes in a Female Mouse Model for Gender-Affirming Testosterone with Improvement in Outcomes Following Cessation of Testosterone Treatment
por: Moravek, Molly B, et al.
Publicado: (2022)

MON-198 Feminizing Regimen Requirements in Transgender Females Following Orchiectomy
por: Korpaisarn, Sira, et al.
Publicado: (2019)

SUN-050 Isolated Hyperprolactinemia Caused by Chest Binding in a Transgender Male
por: Cunningham, Hayley E, et al.
Publicado: (2020)

SAT378 Unusual Case of Hirsutism From Prolactinoma Induced Dihydrotestosterone Elevation
por: Ambalavanan, Jayachidambaram, et al.
Publicado: (2023)

The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapy
por: Yau, Mabel, et al.
Publicado: (2023)

First Evidence of Cardiopulmonary Adaptation to Physical Effort in Transgender Women After Long-Term Hormone Therapy: A Cross-Sectional Study
por: Alvares, Leonardo A M, et al.
Publicado: (2021)

MON-197 Peri-operative Outcomes of Vaginoplasty Using an Individualized Approach to Hormone Management in Transgender Women
por: Davidge-Pitts, Caroline, et al.
Publicado: (2019)

Sexual & reproductive health information on minor consent forms for pubertal suppression and gender affirming hormones
por: Taylor, Julia, et al.
Publicado: (2023)

Achieving Physiologic 17-ẞ-Estradiol Levels in Transgender Females on Estradiol Transdermal Patches and Optimal Dosing
por: Trovato, Alexa, et al.
Publicado: (2021)

SUN-049 Male Pattern Baldness and Waist-Hip Ratio as Markers of Arterial Stiffness in Transgender Men Undergoing Long-Term Testosterone Therapy
por: Alvares, Leonardo Azevedo Mobilia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qt0qgupqmdrnqre3ah1uqpo23r